Recombinant Human Coagulation VIIa Market: Supporting Advances in Specialized Bleeding Management
Blood coagulation is a complex biological process that helps control bleeding following injury. Coagulation factor VIIa plays a role in activating the clotting pathway, and recombinant forms of this protein have been developed for selected bleeding disorders and specialized clinical situations. These medicines are important in areas where carefully managed hemostatic treatment is required. The...
0 Σχόλια 0 Μοιράστηκε 2 Views 0 Προεπισκόπηση